Holen Sie sich die Stockscreener-App
27.82
9.08%
-2.78
Handel nachbörslich:
28.01
0.19
+0.68%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TVTX?
Forum
Prognose
Aktiensplit
Travere Therapeutics Inc Aktie (TVTX) Neueste Nachrichten
How liquid is Travere Therapeutics Inc. stockJuly 2025 Sector Moves & Free Reliable Trade Execution Plans - mfd.ru
Travere Therapeutics (NASDAQ:TVTX) Stock Price Down 7.9%Should You Sell? - MarketBeat
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? - AOL.com
CEO Change: Will Travere Therapeutics Inc. stock benefit from green energy trends2025 Performance Recap & High Return Trade Opportunity Guides - mfd.ru
Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Travere Therapeutics (TVTX) Earnings Expected to Grow: Should You Buy? - Yahoo! Finance Canada
Is Travere Therapeutics Inc. stock heavily shortedJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - mfd.ru
Published on: 2026-02-12 19:23:57 - baoquankhu1.vn
Travere Therapeutics (TVTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Travere Therapeutics at Guggenheim Summit: Confident in Strategic Path By Investing.com - Investing.com Canada
What’s the analyst consensus on Travere Therapeutics Inc.July 2025 Trade Ideas & Safe Swing Trade Setups - mfd.ru
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
161,988 Shares in Travere Therapeutics, Inc. $TVTX Acquired by Essex Investment Management Co. LLC - MarketBeat
Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unveiling a 40.86% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Travere Therapeutics, Inc. $TVTX Shares Sold by Federated Hermes Inc. - MarketBeat
Penserra Capital Management LLC Buys Shares of 80,556 Travere Therapeutics, Inc. $TVTX - MarketBeat
Market Review: Is Travere Therapeutics Inc trading at a discountWeekly Trade Analysis & Low Risk Entry Point Guides - baoquankhu1.vn
Piper Sandler Raises Price Target for TVTX to $38.00 | TVTX Stoc - GuruFocus
Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CFO Sells 1,745 Shares of Stock - MarketBeat
Technical Reactions to TVTX Trends in Macro Strategies - Stock Traders Daily
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit - Business Wire
Travere Therapeutics (NASDAQ:TVTX) Insider Sells $57,301.59 in Stock - MarketBeat
Bank of America Securities Sticks to Its Buy Rating for Travere Therapeutics (TVTX) - The Globe and Mail
Travere Therapeutics (NASDAQ:TVTX) CEO Eric Dube Sells 100,087 Shares - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) Insider Sells $234,797.20 in Stock - MarketBeat
Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CFO Sells 7,242 Shares of Stock - MarketBeat
Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CAO Sells 4,333 Shares of Stock - MarketBeat
William Rote Sells 12,446 Shares of Travere Therapeutics (NASDAQ:TVTX) Stock - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) Insider Sells $230,461.00 in Stock - MarketBeat
Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative? - Yahoo Finance
Published on: 2026-02-01 07:00:12 - baoquankhu1.vn
Lisanti Capital Growth LLC Invests $3.10 Million in Travere Therapeutics, Inc. $TVTX - MarketBeat
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm - GlobeNewswire
Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think - Seeking Alpha
Hussman Strategic Advisors Inc. Has $1 Million Stock Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm - The Malaysian Reserve
TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Laun - GuruFocus
Travere therapeutics CEO Dube sells $1.8 million in TVTX stock By Investing.com - Investing.com Canada
Travere Therapeutics (NASDAQ:TVTX) CEO Sells $244,131.35 in Stock - MarketBeat
Travere Therapeutics (TVTX) Stock Analysis: Exploring a 40% Upside in Rare Disease Biotechnology - DirectorsTalk Interviews
TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses - GlobeNewswire
Universal Beteiligungs und Servicegesellschaft mbH Boosts Holdings in Travere Therapeutics, Inc. $TVTX - MarketBeat
BofA remains positive on Travere despite FDA decision delay for Filspari - MSN
Travere Therapeutics provides corporate update and 2026 outlook - MSN
Trading the Move, Not the Narrative: (TVTX) Edition - Stock Traders Daily
Palisades Investment Partners Acquires $5.26M Stake in Travere Therapeutics - intellectia.ai
Travere Therapeutics (TVTX) Hits Fresh High on Impressive Earnings, Bullish Outlook - MSN
Benign Growth For Travere Therapeutics, Inc. (NASDAQ:TVTX) Underpins Stock's 27% Plummet - simplywall.st
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):